Notice of NIDDK's Participation in PAR-23-237 -Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)
Notice Number:
NOT-DK-24-008

Key Dates

Release Date:

December 15, 2023

Related Announcements

  • August 30, 2023 - Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed). See NOFO PAR-23-237.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this notice is to inform potential applicants that the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) will participate, effective immediately in PAR-23-237, Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed).

The following changes and updates are made to PAR-23-237 (shown in bold italics) to reflect NIDDK’s participation:

Part 1. Overview Information, Participating Organization(s)

National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)

Office of Data Science Strategy (ODSS)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of General Medical Sciences (NIGMS)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Minority Health and Health Disparities (NIMHD)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

Assistance Listing Number(s)

93.847 93.310, 93.394, 93.213, 93.172, 93.866, 93.859, 93.837, 93.838, 93.839, 93.840, 93.233, 93.279, 93.853, 93.867, 93.846, 93.121, 93.113, 93.307, 93.286

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Xujing Wang, Ph.D.
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)
Telephone: 301-451-2862
Email: [email protected]

NIDDK conducts and supports medical research in diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and in kidney, urologic, and hematologic diseases. Potential applicants should contact NIDDK program staff well before the application due date to discuss NIDDK programmatic interests and priorities.Visit NIDDK's Research Programs and Contacts page to identify a scientific/research contact.